Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) [Phase 2]
A Phase 2 clinical trial evaluating oral ISM5411 for active ulcerative colitis is currently recruiting.
-
EMA approval · 2026-03-30EMA Authorised: Uzpruvo (ustekinumab) — Stada Arzneimittel AG
EMA authorised Uzpruvo (ustekinumab) for the treatment of psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis [Phase 2]
Pfizer is conducting a Phase 2 trial to evaluate etrasimod in adolescents with ulcerative colitis, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation [Phase 2]
Phase 2 trial evaluating Aquamin for prevention of J-pouch-associated intestinal inflammation in ulcerative colitis patients. The study stat…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]
Pfizer is conducting a Phase 3 extension study for the treatment of moderately to severely active ulcerative colitis; the trial is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC) [NA]
Sponsored by the University of Miami, this clinical trial is evaluating a tailored anti-inflammatory diet for ulcerative colitis and is curr…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
A clinical trial update describing a study to evaluate the effectiveness of etrasimod in people with ulcerative colitis, currently recruitin…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Intestinal Organoids [NA]
Clinical trial update from Rennes University Hospital describes research using intestinal organoids to study inflammatory bowel diseases, in…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Development of the SC-IBD Self-Care Measurement Scale
This document reports a clinical trial to develop the SC-IBD Self-Care Measurement Scale for inflammatory bowel diseases, including ulcerati…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]
Phase 2 clinical trial evaluating the long-term effects of TEV-48574 in adults with moderate-to-severe Crohn's disease or ulcerative colitis…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt
A clinical trial at Assiut University is evaluating the efficacy of different biological treatments for Crohn's disease and ulcerative colit…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis [NA]
Clinical trial update for chronotherapy of mesalamine (5-aminosalicylic acid) in Ulcerative Colitis; the study is currently active but not r…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
A retrospective real-world study sponsored by AbbVie is evaluating treat-to-target strategies and disease modification in adults with Crohn'…
-
EMA approval · 2026-03-25EMA Authorised: Otulfi (ustekinumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Otulfi, a ustekinumab product from Fresenius Kabi Deutschland GmbH, for Crohn's disease and Ulcerative colitis.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease [NA]
This clinical trial entry documents a pediatric inflammatory bowel disease study examining the impact of physical activity and fitness. The …
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis
AbbVie is conducting an oral upadacitinib study to assess change in disease activity in adults with Ulcerative Colitis; the trial is current…
-
EMA label_change · 2026-03-23EMA Authorised: Tremfya — Janssen-Cilag International NV
EU authorises Tremfya to treat psoriasis, Crohn's disease, and ulcerative colitis.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies [Phase 2]
Phase 2 trial evaluating selenium supplementation in adults with moderate-to-severely active ulcerative colitis who are treated with advance…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Transfer of Feces in Ulcerative Colitis 2 [Phase 2]
A Phase 2 clinical trial evaluating transfer of feces (fecal microbiota transplantation) for ulcerative colitis has completed.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy [NA]
This clinical trial compares virtual chromoendoscopy with dye-based chromoendoscopy for surveillance colonoscopy in inflammatory bowel disea…
-
EMA approval · 2026-03-19EMA Authorised: Libmyris (adalimumab) — Stada Arzneimittel AG
EMA authorised Libmyris (adalimumab) by Stada Arzneimittel AG for multiple inflammatory diseases, expanding treatment options in rheumatoid …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Clinical trial update for a Phase 3 study evaluating Afimkibart (RO7790121) as induction and maintenance therapy in adults with moderately t…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach [Phase 1, Phase 2]
This clinical trial update reports an ongoing Phase 1/2 study comparing single infusion versus sequential fecal microbiota transplantation i…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease [Phase 2]
A Phase 2 master protocol study sponsored by Eli Lilly evaluating multiple drugs in adults with ulcerative colitis or Crohn's disease; curre…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Superdonor FMT in Patients With Ulcerative Colitis [Phase 1, Phase 2]
A clinical trial update for a Superdonor fecal microbiota transplant in patients with active ulcerative colitis, currently recruiting in Pha…